Potent Compound Categorization and Safety

Since 1942, occupational health professionals in the pharmaceutical industry have recognized the potential for occupational disease caused by overexposure to active pharmaceutical ingredients (APIs), potent compounds and hazardous drugs. In their article, Health effects of exposure to active pharmaceutical ingredients (APIs), Heron and Pickering (2003) provided an in-depth review of adverse health effects within the industry.

More recently, the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH) have had limited involvement regarding this issue. Read more…


mm

About Dean Calhoun

view all posts

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software